Activity of bortezomib in glioblastoma.

Abstract:

BACKGROUND:Chemotherapy is the commonly accepted standard therapy for most types of brain tumor, especially in medulloblastoma, primitive neuroectodermal tumor and astrocytoma. However, no efficient therapy has been established to date for glioblastoma multiforme. The aim of the present study was to analyze the activity of bortezomib in glioblastoma cell lines in comparison with that in a pediatric acute lymphoblastic leukemia cell line. MATERIALS AND METHODS:Glioblastoma multiforme T98G, glioblastoma-astrocytoma U373M and T-lineage acute lymphoblastic leukemia CCRF-CEM cell lines were used. Proteasome inhibitor, bortezomib and 14 other anticancer drugs were tested using the MTT assay. RESULTS:Compared to the acute lymphoblastic cell line, both glioblastoma cell lines showed relatively good sensitivity to bortezomib, as well as to cisplatin, carboplatin, etoposide and actinomycin-D. The lines showed intermediate sensitivity to thiotepa and daunorubicin, but were highly resistant to first-line drugs used in the therapy of acute lymphoblastic leukemia, such as prednisolone, L-asparaginase, vincristine, doxorubicin and cytarabine. Bortezomib, which is not a substrate for PGP and MRP1, did not show cross resistance to drugs transported by these proteins. CONCLUSION:Our results support the necessity for further research on the role of bortezomib in the therapy of glioblastoma.

journal_name

Anticancer Res

journal_title

Anticancer research

authors

Styczynski J,Olszewska-Slonina D,Kolodziej B,Napieraj M,Wysocki M

subject

Has Abstract

pub_date

2006-11-01 00:00:00

pages

4499-503

issue

6B

eissn

0250-7005

issn

1791-7530

journal_volume

26

pub_type

杂志文章
  • Visualizing Energy Charge in Breast Carcinoma Tissues by MALDI Mass-spectrometry Imaging Profiles of Low-molecular-weight Metabolites.

    abstract:BACKGROUND/AIM:Metabolomics is widely used for biomarker discovery, but conventional mass-spectrometry extraction procedures lose the spatial localization of metabolites. In this study, we directly analyzed breast carcinoma tissues embedded in frozen tissue microarrays (fTMAs) using MALDI mass-spectrometry imaging (MAL...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.12723

    authors: Torata N,Kubo M,Miura D,Ohuchida K,Mizuuchi Y,Fujimura Y,Hayakawa E,Kai M,Oda Y,Mizumoto K,Hashizume M,Nakamura M

    更新日期:2018-07-01 00:00:00

  • PSA course after definitive high-dose radiotherapy of localized prostate cancer.

    abstract:AIM:After radical prostatectomy, PSA levels that reach near zero values in less than 14 days are associated with a favourable prognosis. The aim of this analysis was to investigate whether PSA also declines to near zero values after combined tele-brachytherapy. MATERIALS AND METHODS:Forty-one patient, treated with com...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Schüller P,Schäfer U,Micke O,Panke JE,Willich N

    更新日期:2005-05-01 00:00:00

  • Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound.

    abstract:BACKGROUND:The effects of resveratrol (a natural polyphenol) on angiogenesis in rat gliomas were investigated by color Doppler ultrasound (CDUS). The correlation among the tumor growth rate, macroscopic angiogenesis measured by CDUS and microscopic angiogenesis was assessed by immunohistochemical staining. MATERIALS A...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Chen JC,Chen Y,Lin JH,Wu JM,Tseng SH

    更新日期:2006-03-01 00:00:00

  • The effect of a biological response modifier, PSK, on the intestinal immune system in tumor-bearing mice.

    abstract::We have previously shown that oral administration of PSK not only exerts antitumor activity, but also restores immune response in tumor-bearing mice. In order to analyze the immunomodulative effect of PSK, we investigated the effects of oral PSK on the intestinal immune systems in ICR mice bearing sarcoma 180. Oral ad...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Matsunaga K,Morita I,Oguchi Y,Fujii T,Yoshikumi C,Nomoto K

    更新日期:1987-05-01 00:00:00

  • Cancer gene therapy: challenges and opportunities.

    abstract::Understanding the molecular basis of human disease has been the corner-stone of rationally designed molecular therapies. Medicine has a long history of treating patients with cell therapies (i.e., blood transfusions) and protein therapies (i.e., growth factors and cytokines). Gene therapies are the newest therapeutic ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Scanlon KJ

    更新日期:2004-03-01 00:00:00

  • Role of chemotherapeutic antagonism in opportunistic infections.

    abstract::The most widely-known anti-tumor drugs often induce marked immunosuppression which can give rise to one or more sepses. Anti-infection measures immediately applied can sometimes prove largely ineffective or even useless, the patient dying not as a result of the spread of the tumour but as a direct consequence of oppor...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Castelli M,Baggio G,Ruberto AI,Malagoli M,Casolari C,Rossi T,Galatulas I

    更新日期:1997-11-01 00:00:00

  • The prognostic significance of autoantibodies against dsDNA in patients with colorectal adenocarcinoma.

    abstract:BACKGROUND:The tumors of the gastrointestinal system have been associated with various immune disorders. The goal of this study was to correlate the presence of the anti-dsDNA autoantibodies in the serum of patients with colorectal adenocarcinoma suffering from the prognosis of their disease. PATIENTS AND METHODS:We i...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Syrigos KN,Charalambopoulos A,Pliarchopoulou K,Varsamidakis N,Machairas A,Mandrekas D

    更新日期:2000-11-01 00:00:00

  • Interaction of chlorpromazine with 2'-deoxyguanosine-5'-monophosphate by PM3 calculation.

    abstract::Using the PM3 method, the interactions between chlorpromazine (CPZ) with 2'-deoxyguanosine-5'-monophosphate (dGMP) were examined. We obtained the optimized geometrical structure of each CPZ, dGMP and a CPZ-dGMP system in both aqueous-phase and gaseous-phase and investigated their geometric and electric changes and For...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kurihara T,Motohashi N,Kobayashi H,Yamanaka W,Dohyashiki S,Molnár J

    更新日期:1998-09-01 00:00:00

  • Pleural effusion as a significant prognostic factor in non-small cell lung cancer.

    abstract:UNLABELLED:In non-small cell lung cancer (NSCLC), pleural effusion is a frequently observed complication, and often provides a treatment difficulties. The aim of this study is to evaluate prognostic significance of pleural effusion in patients with NSCLC. MATERIALS AND METHODS:Seven hundred and eight untreated patient...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Naito T,Satoh H,Ishikawa H,Yamashita YT,Kamma H,Takahashi H,Ohtsuka M,Hasegawa S

    更新日期:1997-11-01 00:00:00

  • Survival and Complication Rates of Metastasectomy in Patients With Metastatic Renal Cell Carcinoma Treated Exclusively With Targeted Therapy: A Combined Population-based Analysis.

    abstract:AIM:This study analyzed the effect of metastasectomy on overall mortality (OM) and perioperative outcomes in patients with metastatic renal cell carcinoma (mRCC) treated exclusively with targeted therapy. MATERIALS AND METHODS:Using the Surveillance, Epidemiology, and End Results (SEER) database (2006-2015), Kaplan-Me...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13604

    authors: Palumbo C,Pecoraro A,Knipper S,Rosiello G,Tian Z,Shariat SF,Simeone C,Briganti A,Saad F,Berruti A,Antonelli A,Karakiewicz PI

    更新日期:2019-08-01 00:00:00

  • Cytogenetical observations and hormone receptor expression in five extra-uterine leiomyomas.

    abstract::The chromosomes were studied by an in vitro technique in four parametrial and one gastric leiomyomas. The findings in parametrial myomas (the present four cases and one published earlier) differed from the observations in uterine cases by the absence of normal stemlines and the absence of 1p,6p and 7q changes. As has ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Havel G,Dahlenfors R,Wedell B,Hogström L,Mark J

    更新日期:1994-09-01 00:00:00

  • Antitumor and antimetastatic effects on liver of triterpenoid fractions of Ganoderma lucidum: mechanism of action and isolation of an active substance.

    abstract::The triterpenoid fraction (100 and 200 mg/kg) of the fruit bodies of Ganoderma lucidum inhibited primary solid-tumor growth in the spleen, liver metastasis and secondary metastatic tumor growth in the liver in intrasplenic Lewis lung carcinoma (LLC)-implanted mice. In addition, the triterpenoid fraction (800 microgram...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Kimura Y,Taniguchi M,Baba K

    更新日期:2002-11-01 00:00:00

  • Biweekly Docetaxel and S-1 combination chemotherapy as first-line treatment for elderly patients with advanced gastric cancer.

    abstract:BACKGROUND/AIM:This study assessed the toxicity and activity of biweekly docetaxel and S-1 combination therapy in elderly patients with advanced gastric cancer. PATIENTS AND METHODS:One-hundred and thirteen patients were enrolled: 35 were 75 years old or more. The objective response rate, toxicity, progression-free su...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Kunisaki C,Takahashi M,Ono HA,Hasegawa S,Tsuchida K,Oshima T,Ota M,Fukushima T,Tokuhisa M,Izumisawa Y,Takagawa R,Kimura J,Kosaka T,Makino H,Akiyama H,Endo I

    更新日期:2013-02-01 00:00:00

  • Reduction of Intrahepatic Tumour by Hepatic Arterial Infusion Chemotherapy Prolongs Survival in Hepatocellular Carcinoma.

    abstract:BACKGROUND/AIM:This study aimed to identify the survival benefit of intrahepatic tumour control by hepatic arterial infusion chemotherapy (HAIC) in hepatocellular carcinoma (HCC) patients with portal vein tumour thrombus (PVTT) or extrahepatic metastasis. PATIENTS AND METHODS:Between 2010 and 2017, a total of 187 cons...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.13542

    authors: Sung PS,Yang K,Bae SH,Oh JS,Chun HJ,Nam HC,Jang JW,Choi JY,Yoon SK

    更新日期:2019-07-01 00:00:00

  • Oxaliplatin fractionated over two days with bimonthly leucovorin and 5-fluorouracil in metastatic colorectal cancer.

    abstract:PURPOSE:To evaluate the efficacy and safety of oxaliplatin (L-OHP) fractionated over two days with bimonthly 5-fluorouracil (5-FU) and leucovorin (LV), as first-line treatment of metastatic colorectal cancer (MCC) patients. PATIENTS AND METHODS:Fifty-four patients with inoperable MCC (median age, 60 years) were entere...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Recchia F,Rea S,Nuzzo A,Lalli A,Di Lullo L,De Filippis S,Saggio G,Biondi E,Massa E,Mantovani G

    更新日期:2004-05-01 00:00:00

  • Microsatellite Instability Is Common in Colorectal Cancer in Native Nigerians.

    abstract:BACKGROUND:Colorectal cancer (CRC) is the fifth most common cancer in Africa, with significant differences in incidence, biology and clinical behavior from other populations. MATERIALS AND METHODS:We studied prevalence and clinicopathological features of microsatellite instability (MSI) and young onset CRC in 83 archi...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11612

    authors: Irabor DO,Oluwasola OA,Ogunbiyi OJ,Ogun OG,Okolo CA,Melas M,Gruber SB,Shi C,Raskin L

    更新日期:2017-05-01 00:00:00

  • Radiotherapy for early-stage primary ocular adnexal mucosa-associated lymphoid tissue lymphoma.

    abstract:BACKGROUND:Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (POAML) is a rare disease. The purpose of this study was to evaluate the treatment outcome and patterns of failure of patients with early-stage POAML treated with radiotherapy. PATIENTS AND METHODS:From 1995 to 2008, 53 patients with early-st...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ohga S,Nakamura K,Shioyama Y,Sasaki T,Yoshitake T,Atsumi K,Terashima K,Asai K,Matsumoto K,Yoshikawa H,Kawano Y,Honda H

    更新日期:2013-12-01 00:00:00

  • Pemetrexed Versus Erlotinib in the Second-line Treatment of Patients with Advanced-stage Non-squamous NSCLC Harboring Wild-type EGFR Gene.

    abstract:BACKGROUND:Pemetrexed and erlotinib represent different agents commonly used for the second-line treatment of patients with advanced-stage non-small cell lung cancer (NSCLC). PATIENTS AND METHODS:We analyzed data of 137 patients with advanced-stage non-squamous NSCLC treated with pemetrexed or erlotinib in the second ...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Fiala O,Pesek M,Finek J,Svaton M,Minarik M,Benesova L,Bortlicek Z,Kucera R,Topolcan O

    更新日期:2016-01-01 00:00:00

  • The role of regulatory T cells in malignant glioma.

    abstract::The aggressive nature of gliomas is closely related to their capacity to evade the anti-tumoral immune response. The mechanisms implicated in this phenomenon are only partially understood. A subset of T cells, termed CD4+ CD25+ regulatory T cells (Treg), have been shown to inhibit the actions of effector lymphocytes. ...

    journal_title:Anticancer research

    pub_type: 杂志文章,评审

    doi:

    authors: Sonabend AM,Rolle CE,Lesniak MS

    更新日期:2008-03-01 00:00:00

  • Novel system for generating cytotoxic effector lymphocytes using carcinoembryonic antigen (CEA) peptide and cultured dendritic cells.

    abstract::We have established a practical system for generating antitumor effector lymphocytes using the tumor antigen peptide CEA and cultured dendritic cells (DCs), and have also characterized effector cells. DCs were induced from the adherent cell population of autologous peripheral blood mononuclear cells (PBMCs) obtained f...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ohta K,Yamaguchi Y,Shimizu K,Miyahara E,Toge T

    更新日期:2002-09-01 00:00:00

  • Lack of correlation between P53 expression, BCL-2 expression, apoptosis and ex vivo chemosensitivity in advanced human breast cancer.

    abstract::The relationship between apoptosis and chemosensitivity remains complex. We tested the chemosensitivity of 45 patients with advanced breast cancer (BC) ex vivo against anthracyclines (A: doxorubicin, epirubicin), taxanes (T: paclitaxel, docetaxel), cisplatin (DDP) and CMF and any correlation with the expression of p53...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rein DT,Schöndorf T,Breidenbach M,Janát MM,Weikelt A,Göhring UJ,Becker M,Mallmann P,Kurbacher CM

    更新日期:2000-11-01 00:00:00

  • Detectable Wilms' tumor-1 transcription at treatment completion is associated with poor prognosis of acute myeloid leukemia: a single institution's experience.

    abstract:BACKGROUND/AIM:The present retrospective study was conducted to measure Wilms' tumor-1 (WT1) mRNA levels in the peripheral blood of patients with acute myeloid leukemia (AML) in order to examine any association with the clinical outcomes. PATIENTS AND METHODS:A total of 58 AML patients were evaluated retrospectively i...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yamauchi T,Negoro E,Lee S,Takai M,Matsuda Y,Takagi K,Kishi S,Tai K,Hosono N,Tasaki T,Ikegaya S,Yoshida A,Urasaki Y,Iwasaki H,Ueda T

    更新日期:2013-08-01 00:00:00

  • A Study of Angiogenesis Markers in Patients with Renal Cell Carcinoma Undergoing Therapy with Sunitinib.

    abstract:BACKGROUND:Sunitinib is a tyrosine kinase inhibitor (TKI) targeting tumour angiogenesis in patients with advanced renal cell carcinoma (RCC). Currently no universally agreed model exists correlating the expression of angiogenesis markers with the success of treatment. PATIENTS AND METHODS:We retrospectively analysed a...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:10.21873/anticanres.11315

    authors: Stubbs C,Bardoli AD,Afshar M,Pirrie S,Miscoria M,Wheeley I,Porfiri E

    更新日期:2017-01-01 00:00:00

  • PS2 expression in BRCA1-associated breast cancers.

    abstract:BACKGROUND:PS2-expression is controlled by estrogens and is a prognostic factor for long-term and post-relapse survival. Breast carcinomas associated with a BRCA1 mutation (BRCA1-BC'S) exhibit many specific features, particularly for ER expression. Our purpose was to determine if pS2-expression was different in BRCA1-B...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Charafe-Jauffre E,Eisinger F,Mathoulin-Portier MP,Sobol H,Jacquemier J

    更新日期:2001-07-01 00:00:00

  • Comparison of hyper-fractionated accelerated and standard fractionated radiotherapy with concomitant low-dose gemcitabine for unresectable pancreatic cancer.

    abstract:BACKGROUND:Concurrent chemoradiotherapy with gemcitabine improves median survival for patients with unresectable pancreatic cancer. Recently, hyperfractionated accelerated radiotherapy (HART) has been used to treat these patients; however, the safety and efficacy are not well defined. PATIENTS AND METHODS:The standard...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章

    doi:

    authors: Maemura K,Shinchi H,Noma H,Mataki Y,Kurahara H,Maeda S,Hiraki Y,Nakajo M,Natsugoe S,Takao S

    更新日期:2008-07-01 00:00:00

  • Combined antitumour activity of mitomycin C, 5-fluorouracil and interleukin-2 against human colon cancer cells.

    abstract::Combined treatment of interleukin-2 (IL-2), 5-fluorouracil (5-FU) and mitomycin C (MMC) is reported to be effective against hepatic metastasis of colon carcinoma. To clarify this modality, we investigated lymphokine activated killer (LAK) activity of human peripheral lymphocytes on colon cancer cell lines by 51Cr rele...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Ishihara M,Kubota T,Watanabe M,Kawano Y,Narai S,Yasui N,Otani Y,Teramoto T,Kitajima M

    更新日期:1999-01-01 00:00:00

  • Prognostic effects and regulation of activin A, maspin, and the androgen receptor in upper urinary tract urothelial carcinoma.

    abstract:BACKGROUND:Molecular mechanisms responsible for carcinogenesis in upper urinary tract urothelial carcinoma (UUTUC) are not yet clear. This study aimed to examine and correlate the subcellular localization of activin A, maspin, and the androgen receptor (AR) with demographic characteristics, pathological grade, and stag...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Rau KM,Chen YJ,Sun MT,Kang HY

    更新日期:2011-05-01 00:00:00

  • Immunocytochemical detection of circulating esophageal carcinoma cells by immunomagnetic separation.

    abstract:BACKGROUND:Recent developments in detection of micrometastasis have revealed a considerable incidence of systemic disease in patients who would previously have been diagnosed as having solid tumours only. The purpose of this study was to investigate the prevalence and clinical significance of circulating carcinoma cell...

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Nakamura T,Yasumura T,Hayashi K,Eguchi R,Ide H,Takasaki K,Kasajima T

    更新日期:2000-11-01 00:00:00

  • Prognostic factors for male breast cancer: similarity to female counterparts.

    abstract:AIM:To assess whether prognostic factors in male (MBC) and female (FBC) breast cancer have similar impact on survival. PATIENTS AND METHODS:Charts for men and women diagnosed with breast cancer referred to the London Regional Cancer Program (LRCP) were reviewed. Patients with distant metastatic diseases were excluded....

    journal_title:Anticancer research

    pub_type: 杂志文章

    doi:

    authors: Yu E,Stitt L,Vujovic O,Joseph K,Assouline A,Au J,Younus J,Perera F,Tai P

    更新日期:2013-05-01 00:00:00

  • Combined treatment with thymosin-alpha1 and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial.

    abstract::22 patients with advanced non-small-cell lung cancer were randomized to receive chemotherapy (ifosfamide) or chemotherapy followed by thymosin alpha1 + low-dose IFNalpha. Chemo-immunotherapy induced an enhanced response rate compared with chemotherapy alone (33% and 10% respectively). Although these differences were n...

    journal_title:Anticancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Salvati F,Rasi G,Portalone L,Antilli A,Garaci E

    更新日期:1996-03-01 00:00:00